This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Tohoku University. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2022
Title: Nobuhiro Kikuchi: Innovator in Pulmonary Hypertension Research
Introduction
Nobuhiro Kikuchi is a prominent inventor based in Miyagi, Japan. He has made significant contributions to the field of pulmonary hypertension through his innovative research and patented inventions. With a total of 3 patents, Kikuchi is recognized for his dedication to improving therapeutic options for this serious condition.
Latest Patents
Kikuchi's latest patents include a prophylactic or therapeutic agent for pulmonary hypertension that comprises mebendazole and/or itraconazole or a salt thereof. The objective of this invention is to provide a novel preventive or therapeutic agent for pulmonary hypertension, utilizing compounds that have not previously been known for their therapeutic effects on this condition. Another notable patent is a method for testing for pulmonary hypertension, which aims to offer a convenient and accurate testing process. This method uses the concentration of selenoprotein P protein in a sample derived from a subject as an indicator for the condition.
Career Highlights
Kikuchi is affiliated with Tohoku University, where he conducts his research and develops his inventions. His work has garnered attention in the medical community, particularly for its potential to enhance treatment options for patients suffering from pulmonary hypertension.
Collaborations
Kikuchi has collaborated with notable colleagues such as Hiroaki Shimokawa and Kimio Satoh, contributing to the advancement of research in pulmonary hypertension.
Conclusion
Nobuhiro Kikuchi's innovative work in the field of pulmonary hypertension showcases his commitment to improving patient outcomes through research and invention. His contributions are paving the way for new therapeutic approaches and testing methods in this critical area of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
